The scientific case for pausing NIAID's intranasal whole-virus platforms: direct olfactory-nerve access to the brain, full structural proteins including spike, and the exact networks Dr. Annelise Bocquet mapped in 2025 now running U.S. policy.
The median 18-day gap from COVID symptom onset to death in nursing homes points to secondary bacterial pneumonia a treatable condition often overlooked as protocols tightened and empiric antibiotics were delayed.
An examination of various viewpoints and data related to the COVID-19 pandemic, focusing on scientific studies, public health policies, and reported adverse events. This includes a review of different perspectives on vaccine efficacy and safety, testing methodologies, and associated public health responses.